| Summary: | Objective:The main aim of the study was to investigate the effect of Omega-3 use on the formation of striae gravidarum in pregnant women.Method:In 2020 and 2021, 201 primigravida pregnant women who had at least four antenatal check-ups in a first-trimester pregnancy outpatient clinic and gave birth in the same center were included in the study. These patients were grouped according to the drugs they used (Omega-3 group, multivitamin and irregular medication group). Age, education level, weight gained during pregnancy, history of the additional disease, medication use and birth weight of the baby was recorded. During pregnancy follow-up and at the 24th hour of birth, striae in four parts of the body (abdomen, hips, buttocks, and breasts) were scored according to their color and number with the scoring system developed by Atwal et al.Results:A severe striae score was detected in one puerperium in the patients included in the study. Striae started between 21 and 24 weeks in about one-third of the patients (26.9%). There was a significant difference between the SG scores of pregnant women on regular medication and those on the irregular medication (p<0.001). Pregnant women on irregular medication had a higher postpartum striae score. There was also a positive correlation between SG score and young pregnancy, high weight gain during pregnancy, and early onset of striae. No significant correlation was found between infant weight and SG score (p>0.05).Conclusion:According to the results of our study, a regular multivitamin along with Omega-3 reduces the occurrence of striae gravidarum.
|
|---|